Science

Light and ultrasound reveal renewable routes to compounds for pharmaceutical research

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/10/2026, 19:25:25 UTC.

Briefings

Two studies by Colmenares' group at IPC PAS show that pharmaceutical compound synthesis can begin with cleaner chemistry at the single-bond level, published in Ultrasonics Sonochemistry and Chemistry. The research addresses the reliance on fossil feedstocks and harsh conditions in traditional synthesis.

Key points

• Two studies published in Ultrasonics Sonochemistry and Chemistry by Colmenares' group at IPC PAS demonstrate cleaner chemistry starting at the single-bond level for pharmaceutical synthesis.
• The research addresses the current reliance on fossil feedstocks and harsh conditions like high temperatures and strong oxidants in traditional synthesis methods.

Context

Pharmaceutical compound synthesis traditionally depends on fossil feedstocks and harsh conditions, while sustainable packaging is only the beginning of the solution.

Limitations

Evidence is limited to two published studies from Colmenares' group at IPC PAS, published in Ultrasonics Sonochemistry and Chemistry, with no additional background or data provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/10/2026, 19:26:57 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeigv2xvunkeyftyhbmwcgyaqdpsiukkixesit3h6tz3qkr7hy6cdey